Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.285 USD | +7.39% | +12.63% | -53.54% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.54% | 338M | |
+4.41% | 111B | |
+11.01% | 105B | |
-12.05% | 22.34B | |
-3.87% | 21.93B | |
-6.08% | 18.59B | |
-36.52% | 18.12B | |
-10.04% | 16.96B | |
+3.40% | 13.7B | |
+37.05% | 12.45B |
- Stock Market
- Equities
- AVXL Stock
- News Anavex Life Sciences Corp.
- Anavex Life Sciences Begins European Marketing Authorization Process for Blarcamesine to Treat Alzheimer's Disease